Denali Therapeutics Inc. (DNLI)
NASDAQ·Healthcare·Biotechnology
$20.61
-4.58%
Mkt Cap $3.23B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
Implied Upside
+67.9%
Consensus $34.60 vs current $20.61
NASDAQ·Healthcare·Biotechnology
$20.61
-4.58%
Mkt Cap $3.23B
Buy
10
Hold
0
Sell
0
Price Target (21 analysts)
$34.60
Range $26.00 – $41.00
+67.9%
Consensus $34.60 vs current $20.61